ArticleFrontiers in pharmacology2022

Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience.

Valentina Giudice et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.